Novel therapies for atherosclerosis

As a large multinational corporation operating in the healthcare sector, we are looking for certain new technologies to license or acquire.

Overview

We are committed to the development of novel therapies to increase lifespan and improve the quality of life by reducing the risk, prevalence, and impact of atherosclerosis.

Area of Interest

Technical/Discovery

- Biochemical markers, imaging technologies and relevant animal models to study the vulnerable plaque

Target Areas

- Reversed cholesterol transport by increasing ApoA1, HDL or other relevant mechanism

- Anti-inflammatory compounds relevant to plaque stability (adhesion molecules)

- Parental compounds for high risk atherosclerosis patients (i.e. ApoA1 mimetics)